Kamil Pabis: Why Health Hits a Ceiling, Longevity Needs Drugs & Science Moves Too Slowly - E666

Kamil Pabis , a longevity researcher based in Singapore, joins Jeremy Au to unpack why extending a healthy lifespan needs systems thinking, not quick hacks. They define longevity as targeting aging itself, explain why academia both enables and constrains progress, and show how Singapore’s policy choices support longer lives. They also discuss the biohacker pipeline, the promise of drugs like rapamycin, and why regulation and trial design slow real proof in humans. 06:40 Longevity targets the underlying aging process: Kamil explains that doctors treat a disease, but longevity research aims at the shared driver be...